Adicet Bio, Inc. (ACET) › Operating IncomeAdicet Bio, Inc. (ACET) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$18.88M2018: -$14.96M2019: -$31.39M2020: -$39.19M2021: -$61.43M2022: -$72.55M2023: -$152.04M2024: -$127.61M2025: -$122.11M-$122.11M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$122.11M+4.3%2024-$127.61M+16.1%2023-$152.04M-109.6%2022-$72.55M-18.1%2021-$61.43M-56.8%2020-$39.19M-24.9%2019-$31.39M-109.8%2018-$14.96M+20.7%2017-$18.88M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share